Tissue distribution of the molybdenum hydroxylases, aldehyde

  • C. Beedham
  • S. E. Bruce
  • D. J. Rance
Article

Summary

The activity of the molybdenum hydroxylase, aldehyde oxidase, was determined in crude homogenates and (NH4)2S04 fractions prepared from guinea pig liver, lung, kidney, intestine, spleen and heart. Xanthine oxidase was also measured in (NH4)2S04 fractions. In each case, xanthine oxidase levels were lower than those of aldehyde oxidase; activity of the latter enzyme was highest in the liver, whereas xanthine oxidase was predominant in the small intestine. There was no significant difference in the activity of either molybdenum hydroxylase between tissues taken from male and female guinea pigs.

Key words

Tissue distribution molybdenum hydroxylases guinea pig 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Beedham C. (1985): Molybdenum hydroxylases as drugmetabolising enzymes. Drug Metab. Rev., 16, 119–156.CrossRefPubMedGoogle Scholar
  2. 2.
    Knox W.E. (1946): The quinine-oxidising enzyme and liver aldehyde oxidase. J. Biol. Chem., 163, 699–711.Google Scholar
  3. 3.
    Fabre G., Seither R., Goldman I.D. (1986): Hydroxylation of 4-aminofolates by partially purified aldehyde oxidase from rabbit liver. Biochem. Pharmacol., 35, 1325–1330.CrossRefPubMedGoogle Scholar
  4. 4.
    Beedham C, Bruce S.E., Critchley D.C., Al-Tayib Y., Ranee D.J. (1987): Species variation in hepatic aldehyde oxidase activity. Eur. J. Drug Metab. Pharmacokinet. (This issue).Google Scholar
  5. 5.
    Badwey J.A., Robinson J.M., Karnovsky M.J., Karnovsky M.L. (1981): Superoxide production by an unusual aldehyde oxidase in guinea pig granulocytes. J. Biol. Chem., 256, 3479–3486.PubMedGoogle Scholar
  6. 6.
    Beedham C. (1986): Similarity of aldehyde oxidase from guinea pig liver and polymorphonuclear leucocytes. J. Pharm. Pharmacol., 38, 57–58.PubMedGoogle Scholar
  7. 7.
    Beedham C. (1987): Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity. In: Ellis G.P., West G.B., eds. Progress in medicinal chemistry, Vol. 24. Elsevier Biomedical Division: Amsterdam, pp 85–127.CrossRefGoogle Scholar
  8. 8.
    Johnson C, Beedham C, Stell J.G.P. (1987): Reaction of 1-amino- and 1-chloro-phthalazine with mammalian molybdenum hydroxylases in vitro. Xenobiotica, 17, 17–24.CrossRefPubMedGoogle Scholar
  9. 9.
    Johnson C, Stubley-Beedham C, Stell J.G.P. (1984): Elevation of molybdenum hydroxylase levels in rabbits after ingestion of phthalazine or its hydroxylated metabolite. Biochem. Pharmacol., 33, 3699–3705.CrossRefPubMedGoogle Scholar
  10. 10.
    Huff S.D., Chaykin S. (1967): Genetic and androgenic control of N-methylnicotinamide oxidase activity in mice. J. Biol. Chem., 242, 1265–1270.PubMedGoogle Scholar
  11. 11.
    Levinson D.J., Decker D.E. (1984): Biochemical mechanisms for sex specific differences of rat liver xanthine oxidase. Adv. Exp. Med. Biol., 165A, 511–517.Google Scholar
  12. 12.
    Gibson G.G., Skett P. (1986): Introduction to drug metabolism. Chapman and Hall: London.Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • C. Beedham
    • 2
  • S. E. Bruce
    • 2
  • D. J. Rance
    • 1
  1. 1.Department of Drug MetabolismPfizer Central ResearchSandwichUK
  2. 2.School of Pharmaceutical ChemistryUniversity of BradfordBradfordUK

Personalised recommendations